Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 化学 色谱法
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
verna完成签到 ,获得积分10
17秒前
超级翰完成签到 ,获得积分10
23秒前
xiaojinyu131完成签到,获得积分10
27秒前
湛荏染完成签到,获得积分10
27秒前
mufcyang完成签到,获得积分10
29秒前
风想随心完成签到,获得积分10
30秒前
隐形期待应助科研通管家采纳,获得50
32秒前
allen1994完成签到,获得积分10
32秒前
xiaojinyu完成签到,获得积分10
37秒前
小金鱼1完成签到,获得积分10
42秒前
暴躁的代亦完成签到,获得积分10
47秒前
luckweb发布了新的文献求助10
49秒前
奥特曼完成签到,获得积分10
59秒前
luckweb发布了新的文献求助10
1分钟前
王亚楠完成签到 ,获得积分10
1分钟前
墨z完成签到 ,获得积分10
1分钟前
Arctic完成签到 ,获得积分10
1分钟前
又又完成签到,获得积分0
1分钟前
时尚的访琴完成签到 ,获得积分10
1分钟前
123完成签到 ,获得积分10
1分钟前
鱼儿完成签到,获得积分20
1分钟前
笨笨忘幽完成签到,获得积分0
1分钟前
zachary009完成签到 ,获得积分10
1分钟前
CLTTT完成签到,获得积分0
1分钟前
加贝火火完成签到 ,获得积分10
1分钟前
辣椒小皇纸完成签到,获得积分10
1分钟前
acat完成签到 ,获得积分10
1分钟前
诚心的海白完成签到 ,获得积分10
1分钟前
大海完成签到 ,获得积分10
1分钟前
呆橘完成签到 ,获得积分10
2分钟前
咩咩咩完成签到 ,获得积分10
2分钟前
喵了个咪完成签到 ,获得积分10
2分钟前
心无杂念完成签到 ,获得积分10
2分钟前
2分钟前
害羞的雁易完成签到 ,获得积分10
2分钟前
Alvin完成签到 ,获得积分10
2分钟前
2分钟前
辣椒完成签到,获得积分10
2分钟前
Thalassa完成签到 ,获得积分10
2分钟前
柯彦完成签到 ,获得积分10
2分钟前
高分求助中
Markov Chain Monte Carlo 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Advanced Weaponeering Fourth Edition, Volume 2 1000
Weaponeering: An Introduction Fourth Edition, Volume 1 1000
悉尼大学博士学位论文,题目:Modelling and testing of one-sided stitched laminated composites. 作者:Kristopher P. Plain 700
Matrix Methods in Data Mining and Pattern Recognition Second Edition 610
The Redesign of International Investment Contracts 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7537017
求助须知:如何正确求助?哪些是违规求助? 9121990
关于积分的说明 19486154
捐赠科研通 7135223
什么是DOI,文献DOI怎么找? 3257516
关于科研通互助平台的介绍 2424886
邀请新用户注册赠送积分活动 2245479